The need for effective, evidence-based dialogue between manufacturers and payers has never been greater. In this session, experts will review the recently released AMCP Format for Formulary Submissions, v. 5.0, highlighting how it can support effective, bidirectional communication between manufacturers and payers. Join us to learn more about the updated Format, and gain insights on best practices to support early and ongoing scientific exchange.